Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCZ696 versus amlodipine metabolic effects study in obese hypertensive adults
NL-OMON40044Phase 2Active, not recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in essential hypertension and obesity comparing LCZ696 with amlodipine (2 arms). Primary endpoint: Insulin sensitivity. Started Oct 2012; status: active, not recruiting.
02
Drugs
sacubitril + valsartanamlodipine
03
Conditions
essential hypertensionobesity
Beyond the preview
Go deeper on NL-OMON40044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40044.